Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4863802 | 0.90 | ELANE (0.53) | TPMTELANEKMT2AMEN1POLB | |
| SCHEMBL17044564 | 0.90 | ELANE (0.53) | TPMTELANEKMT2AMEN1POLB | |
| SCHEMBL19157832 | 0.86 | ELANE (0.47) | TPMTELANEKMT2AMEN1HTT | |
| SCHEMBL2431902 | 0.86 | ELANE (0.47) | TPMTELANEKMT2AMEN1HTT | |
| SCHEMBL10148962 | 0.82 | TPMT (0.59) | TPMTELANEHCAR1KMT2AMEN1 | |
| SCHEMBL30031930 | 0.82 | TPMT (0.59) | TPMTELANEHCAR1KMT2AMEN1 | |
| SCHEMBL19335905 | 0.81 | ELANE (0.45) | ELANEKMT2APOLBAPEX1HTT | |
| SCHEMBL15388887 | 0.79 | ELANE (0.42) | ELANEHCAR1KMT2AMEN1POLB | |
| SCHEMBL1433687 | 0.78 | TPMT (0.53) | TPMTHCAR1KMT2AMEN1POLB | |
| SCHEMBL15357797 | 0.78 | ELANE (0.53) | ELANEKMT2AMEN1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111320-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| EP-3326711-B1 | GRAFT COPOLYMER FUNCTIONALIZED ARTICLE | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-2675783-B1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3259323-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10471398-B2 | Graft copolymer functionalized article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-12 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| EP-3502092-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2019-06-26 | — | — | EP | disclosed |
| US-10144760-B2 | Ligand functional substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-12-04 | — | — | US | disclosed |
| US-20030212210-A1 | Reactive oligomers | 3M INNOVATIVE PROPERTIES COMPANY | 2003-11-13 | — | — | US | disclosed |
| US-6635690-B2 | Step growth crosslinkable materials | 3M INNOVATIVE PROPERTIES COMPANY | 2003-10-21 | — | — | US | disclosed |
| US-20030114553-A1 | Hardenable self-supporting structures and methods | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2003-06-19 | — | — | US | disclosed |
| US-20030096908-A1 | Reactive oligomers | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-22 | — | — | US | disclosed |
| WO-2003015720-A1 | HARDENABLE SELF-SUPPORTING STRUCTURES AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2002102909-A1 | REACTIVE OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-12-27 | — | — | WO | disclosed |
| US-20020132927-A1 | Pressure sensitive adhesives possessing high load bearing capability | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-19 | — | — | US | disclosed |
| US-6448337-B1 | CURABLE SYRUP COMPRISING DUAL POLYMERS CONTAINING PENDANT INTERREACTIVE GROUPS, FREE RADICAL POLYMERIZABLE SOLVENT MONOMER AND PHOTOINITIATOR; BALANCED ADHESIVE AND COHESIVE CHARACTERISTICS | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-1230315-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M Innovative Properties Company (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2002038694-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TPMT 4639/4885ELANE 2991/4885HCAR1 4436/4885 |
| US-10144760-B2 | Ligand functional substrates | PCNA, POLM, POLL | TPMT 4554/4885ELANE 1666/4885HCAR1 2142/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | TPMT 4728/4885ELANE 748/4885HCAR1 1302/4885 |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | TPMT 4639/4885ELANE 2991/4885HCAR1 4436/4885 |
| US-11111320-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TPMT 4639/4885ELANE 2991/4885HCAR1 4436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.